Phytoestrogens have the potential to maintain bone health and delay or prevent
osteoporosis. This review focuses on their dose-dependent effects on bone and their …

Osteoporosis refers to excessive bone loss as reflected by the deterioration of bone mass
and microarchitecture, which compromises bone strength. It is a complex multifactorial …

Isoflavones have a structure similar to 17β-estradiol, so they may be useful to
postmenopausal women in preventing bone loss related to estrogen deficiency. The present …

Introduction: Osteoporosis is a highly prevalent skeletal disorder characterized by
compromised bone strength, usually related to decreased bone mass and microstructural …

Osteoporosis (OP) is a metabolic disease that affects bone, resulting in a progressive
decrease in bone mass, quality, and micro-architectural degeneration. Natural products …

During the last 40 years, understanding of bone biology and the pathogenesis of
osteoporosis, the most common and impactful bone disease of old age, has improved …

Osteoporosis is partly genetically determined. The genetics of osteoporosis is polygenic in
nature with multiple common polymorphic alleles interacting with each other and …

Bone loss with increasing age induces osteoporosis. This loss may be due to increased
bone resorption and decreased bone formation. Osteoporosis with a decrease in bone mass …

The skeleton is a metabolically active organ undergoing continuously remodelling. With
ageing and menopause the balance shifts to increased resorption, leading to a reduction in …

Osteoporosis is a major public health concern affecting millions of people worldwide and
resulting in significant economic costs. The condition is characterized by changes in bone …